CLINUVEL PHARMACEUTICALS LTD
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$5.07
-1.55%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 74 observations · as of Oct 30, 2026
1 month
-10.4%
3 months
-26.6%
6 months
—
1 year
-31.2%
Year to date
-31.2%
52-week range
$4.94 – $7.76
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$255.7M
P/E
11
P/B
1.4
P/S
4
Revenue
$64.32M
Net income
$23.18M
Diluted EPS
0.46
Gross margin
82.90%
Net margin
36.00%
Return on equity
13.40%
Total debt
$1.34M
Cash
$13.91M
Free cash flow
$11.85M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CUVL news
All market newsNo ticker-linked stories are in the current archive.